Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,700
Closed -$306K 3561
2025
Q2
$306K Sell
4,700
-1,800
-28% -$108K ﹤0.01% 2872
2025
Q1
$402K Buy
+6,500
New +$431K ﹤0.01% 2414
2023
Q2
Sell
-3,000
Closed -$242K 2648
2023
Q1
$242K Sell
3,000
-900
-23% -$72.5K ﹤0.01% 2070
2022
Q4
$290K Sell
3,900
-3,600
-48% -$256K 0.01% 1923
2022
Q3
$483K Buy
+7,500
New +$520K 0.01% 1428
2021
Q4
Sell
-5,600
Closed -$414K 2674
2021
Q3
$414K Buy
+5,600
New +$420K 0.01% 1783

Other funds holding HOLX

Paul Tudor Jones's HOLX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,196,804 shares — an estimated $166M sold.

Paul Tudor Jones first reported a position in HOLX in Q3 2013 and held it in 26 quarters. The position peaked at $166M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Paul Tudor Jones reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 2,196,804 Hologic shares in Q2 2026, an estimated $166M.
  • Paul Tudor Jones first reported a position in Hologic in Q3 2013 and held it in 26 quarters.
  • Paul Tudor Jones's Hologic position peaked at $166M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.